Literature DB >> 8403735

Protein binding and stereoselectivity of nonsteroidal anti-inflammatory drugs.

F Lapicque1, N Muller, E Payan, N Dubois, P Netter.   

Abstract

Stereoselective binding of nonsteroidal anti-inflammatory drugs (NSAIDs) can be studied using various techniques. Thus the results obtained by different investigators may be poorly consistent and even contradictory. NSAIDs are bound stereoselectively to serum albumin to different degrees depending on the drug investigated (ibuprofen, indoprofen, carprofen, etodolac, ketoprofen and flurbiprofen). For other drugs, both enantiomers are bound to a similar extent (pirprofen, fenoprofen). This stereoselectivity could vary with experimental conditions, in particular with protein concentration (ketoprofen, etodolac), leading to individual differences. Finally, the stereoselectivity of protein binding and of pharmacokinetics can be compared: differences in binding between enantiomers can explain their differences in pharmacokinetics, once metabolic properties such as inversion have been taken into account.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403735     DOI: 10.2165/00003088-199325020-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  51 in total

1.  Further characterization of specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

2.  Interaction of several coumarin compounds with human and canine plasma albumin.

Authors:  R A O'Reilly
Journal:  Mol Pharmacol       Date:  1971-03       Impact factor: 4.436

3.  Binding of pirprofen to human serum albumin studied by dialysis and spectroscopy techniques.

Authors:  M Otagiri; K Masuda; T Imai; Y Imamura; M Yamasaki
Journal:  Biochem Pharmacol       Date:  1989-01-01       Impact factor: 5.858

4.  Pharmacokinetic implications of stereoselective changes in plasma-protein binding: warfarin/sulfinpyrazone.

Authors:  S Toon; W F Trager
Journal:  J Pharm Sci       Date:  1984-11       Impact factor: 3.534

5.  The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis.

Authors:  M A Young; L Aarons; S Toon
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

6.  Pharmacokinetics of the R(-) and S(+) enantiomers of ibuprofen in the serum and synovial fluid of arthritis patients.

Authors:  S R Cox; E P Gall; K K Forbes; M Gresham; G Goris
Journal:  J Clin Pharmacol       Date:  1991-01       Impact factor: 3.126

7.  The disposition of ketoprofen enantiomers in man.

Authors:  B C Sallustio; Y J Purdie; A G Whitehead; M J Ahern; P J Meffin
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

8.  Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

Review 9.  The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences.

Authors:  J Caldwell; A J Hutt; S Fournel-Gigleux
Journal:  Biochem Pharmacol       Date:  1988-01-01       Impact factor: 5.858

10.  Stereoselective disposition of ibuprofen enantiomers in man.

Authors:  E J Lee; K Williams; R Day; G Graham; D Champion
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

View more
  5 in total

1.  Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domains.

Authors:  Da Shi; Yin-xiu Jin; Yi-hong Tang; Hai-hong Hu; Si-yun Xu; Lu-shan Yu; Hui-di Jiang; Su Zeng
Journal:  Acta Pharmacol Sin       Date:  2012-05       Impact factor: 6.150

2.  Enantiomer-specific ketorolac pharmacokinetics in young women, including pregnancy and postpartum period.

Authors:  Aida Kulo; Anne Smits; Sanita Maleškić; Marc Van de Velde; Kristel Van Calsteren; Jan De Hoon; Rene Verbesselt; Jan Deprest; Karel Allegaert
Journal:  Bosn J Basic Med Sci       Date:  2017-02-21       Impact factor: 3.363

3.  In vitro plasma protein binding of zileuton and its N-dehydroxylated metabolite.

Authors:  J M Machinist; M J Kukulka; B A Bopp
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

4.  Pharmacokinetics and efficacy of low-dose ketoprofen in postoperative dental pain.

Authors:  R A Seymour; P J Kelly; J E Hawkesford
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 5.  Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  J R Brouwers; P A de Smet
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.